AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study

Clinical trial NCT05028660 · COMPLETED

Trial details

NCT number: NCT05028660
Sponsor: Elypta
Status: COMPLETED
Study type: OBSERVATIONAL

Muscle-Invasive Bladder Carcinoma

Start date: 2021-07-21
Primary completion: 2025-04-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.